BackStarling Oncology Overview

Starling Oncology Inventory

Track Starling Oncology's inventory ($20M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$20.01M
↑ 26.76% YoYΔ $4.22M vs prior year quarter

Peer trimmed avg / median

Loading

Starling Oncology Inventory History

Loading

Starling Oncology vs. peers: Inventory Comparison

Loading

Starling Oncology Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Starling Oncology (STLN) FAQ

The latest inventory for STLN is $20M as of June 2026. That compares with $16M in the prior-year period — up 26.8% year over year. Investors often review this figure alongside Starling Oncology's historical trend and sector peers before judging valuation or financial health.

Over the past year, STLN's inventory moved from $16M to $20M — a 26.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Starling Oncology's operating scale or balance-sheet position.

A inventory figure of $20M for STLN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting STLN's inventory ($20M), review year-over-year change from $16M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.